{"id":341290,"date":"2025-08-20T14:29:36","date_gmt":"2025-08-20T14:29:36","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-inovio-pharmaceuticals\/"},"modified":"2025-08-20T14:29:36","modified_gmt":"2025-08-20T14:29:36","slug":"how-to-buy-inovio-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","title":{"rendered":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares &#8211; Investment in Inovio Pharmaceuticals, Inc. (INO) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-341290","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Inovio Pharmaceuticals, Inc. (INO) Shares - Investment in Inovio Pharmaceuticals, Inc. (INO) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Inovio Pharmaceuticals, Inc. (INO) Shares - Investment in Inovio Pharmaceuticals, Inc. (INO) Stock"},"description":"Learn how to invest in Inovio Pharmaceuticals (INO) stock with current price analysis, risk assessment, and step-by-step buying process for 2025 opportunities.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to invest in Inovio Pharmaceuticals (INO) stock with current price analysis, risk assessment, and step-by-step buying process for 2025 opportunities."},"intro":"Thinking about diving into the high-stakes world of biotech investing? Inovio Pharmaceuticals (INO) represents one of the most exciting\u2014and volatile\u2014opportunities in the healthcare sector right now. With a groundbreaking DNA medicine platform and a potential FDA approval on the horizon, this stock could either skyrocket or crash spectacularly. We'll break down everything you need to know about how to buy Inovio Pharmaceuticals, Inc. (INO) shares and whether this investment fits your risk appetite.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about diving into the high-stakes world of biotech investing? Inovio Pharmaceuticals (INO) represents one of the most exciting\u2014and volatile\u2014opportunities in the healthcare sector right now. With a groundbreaking DNA medicine platform and a potential FDA approval on the horizon, this stock could either skyrocket or crash spectacularly. We'll break down everything you need to know about how to buy Inovio Pharmaceuticals, Inc. (INO) shares and whether this investment fits your risk appetite."},"body_html":"<h2>\ud83d\udcc8 Inovio Stock: Current Price and Critical Dates<\/h2> <p>As of August 20, 2025, Inovio Pharmaceuticals (INO) trades at <strong>$1.94<\/strong> per share. But here's where it gets interesting\u2014mark your calendar for <strong>November 13, 2025<\/strong>. That's when INO releases its Q3 earnings, and historically, these reports have been absolute game-changers for this volatile biotech stock.<\/p> <h3>How FDA News Moves INO Stock<\/h3> <p>Let me show you something eye-opening about this company's price sensitivity:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Pre-News Price<\/th><th>Post-News Change<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 12, 2025<\/td><td>Q2 Earnings<\/td><td>$1.82<\/td><td><strong>+6.6%<\/strong> (BLA progress)<\/td><\/tr> <tr><td>July 7, 2025<\/td><td>$25M Offering<\/td><td>$1.75<\/td><td><strong>-8.2%<\/strong> (dilution fears)<\/td><\/tr> <tr><td>May 15, 2025<\/td><td>Device Testing Complete<\/td><td>$1.68<\/td><td><strong>+12.3%<\/strong> (regulatory milestone)<\/td><\/tr> <tr><td>March 10, 2025<\/td><td>Breakthrough Therapy Designation<\/td><td>$2.10<\/td><td><strong>+18.9%<\/strong> (FDA recognition)<\/td><\/tr> <tr><td>January 25, 2025<\/td><td>Corporate Update<\/td><td>$1.95<\/td><td><strong>-4.1%<\/strong> (mixed sentiment)<\/td><\/tr> <tr><td>November 8, 2024<\/td><td>Clinical Data Publication<\/td><td>$2.25<\/td><td><strong>+22.7%<\/strong> (trial success)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Insight<\/strong>: Positive FDA-related news typically sends INO soaring 15-25%, while financing activities cause immediate 5-10% dips. The stock reacts violently to regulatory milestones\u2014perfect for quick trading opportunities if you time it right.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd04 6-Month Price Journey (February-August 2025)<\/h2> <p>INO has been on an absolute rollercoaster ride, losing a staggering <strong>70.76%<\/strong> of its value over the past six months. Here's how the carnage unfolded:<\/p> <p><strong>February<\/strong>: $6.20 (pre-earnings optimism)<br> <strong>March<\/strong>: $4.85 (clinical trial concerns)<br> <strong>May<\/strong>: $3.10 (financing worries)<br> <strong>July<\/strong>: $1.75 (dilution from public offering)<br> <strong>August<\/strong>: $1.94 (recent BLA progress bounce)<\/p> <p>Why the dramatic collapse? The company burned through cash at an alarming rate, reporting a <strong>$43.2 million year-to-date loss<\/strong> with only $182,340 in revenue. Management even expressed \"substantial doubt about the company's ability to continue as a going concern beyond Q2 2026.\" Ouch.<\/p> <p>But here's the twist\u2014despite the bloodbath, INO recently showed signs of life with a <strong>31.1% two-week surge<\/strong> as BLA submission plans gained traction. This is biotech investing at its most extreme!<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2> <p>Now for the million-dollar question\u2014where's this stock headed?<\/p> <ul> <li><strong>2025 (Year-End)<\/strong>: $2.50-4.00 \u2192 <strong>HOLD<\/strong> (wait for BLA submission confirmation)<\/li> <li><strong>2026<\/strong>: $8-18 if FDA approved \u2192 <strong>BUY<\/strong> (analyst consensus target: $8.80)<\/li> <li><strong>2028<\/strong>: $15-30 if commercial success \u2192 <strong>STRONG BUY<\/strong> (market expansion)<\/li> <li><strong>2030<\/strong>: $40-60 if pipeline delivers \u2192 <strong>AGGRESSIVE BUY<\/strong> (blockbuster potential)<\/li> <\/ul> <p><strong>Verdict<\/strong>: This is a binary bet\u2014either FDA approval makes you rich, or rejection wipes you out. Only risk capital should apply.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks That Keep Traders Awake at Night<\/h3> <ul> <li><strong>FDA rejection risk<\/strong>: BLA submission doesn't guarantee approval<\/li> <li><strong>Financial collapse<\/strong>: Company may not survive until 2026 without more funding<\/li> <li><strong>Extreme volatility<\/strong>: 14.6% average weekly swings will test your nerves<\/li> <li><strong>Dilution danger<\/strong>: More share offerings likely needed<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>BLA on track<\/strong>: Second-half 2025 submission planned<\/li> <li><strong>Breakthrough designation<\/strong>: FDA fast-track status secured<\/li> <li><strong>Clinical success<\/strong>: 86% of patients showed surgical reduction<\/li> <li><strong>Device ready<\/strong>: CELLECTRA 5PSP testing completed<\/li> <li><strong>Orphan drug status<\/strong>: Additional regulatory advantages<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start microscopic<\/strong>: Allocate no more than 1-2% of your portfolio to this speculation<\/li> <li><strong>Wait for November<\/strong>: Q3 earnings on November 13th will provide crucial updates<\/li> <li><strong>Set tight stops<\/strong>: This stock can gap down 30% overnight on bad news<\/li> <li><strong>Diversify heavily<\/strong>: Balance with stable blue-chips to survive the volatility<\/li> <\/ol> <p>Humorous take: \"Trading INO is like performing brain surgery with a chainsaw\u2014thrilling to watch, but you wouldn't want to be the patient without proper protection!\"<\/p> <h2>\u2705 How to Buy Inovio Pharmaceuticals, Inc. (INO) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ listings and fractional shares<\/td><\/tr> <tr><td>2<\/td><td>Complete account verification<\/td><td>Most platforms require ID and proof of address<\/td><\/tr> <tr><td>3<\/td><td>Deposit funds<\/td><td>Start with small amounts given the high risk<\/td><\/tr> <tr><td>4<\/td><td>Search \"INO\"<\/td><td>Use the ticker symbol, not the company name<\/td><\/tr> <tr><td>5<\/td><td>Select order type<\/td><td>Use limit orders to control entry price in volatile stocks<\/td><\/tr> <tr><td>6<\/td><td>Review and confirm<\/td><td>Check commission fees\u2014aim for less than 1%<\/td><\/tr> <tr><td>7<\/td><td>Monitor position<\/td><td>Set price alerts for this extremely volatile stock<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits INO Trading<\/h2> <p>Trading volatile biotech stocks like INO requires a platform that understands quick movements and risk management. Pocket Option offers:<\/p> <ul> <li><strong>$5 minimum deposit<\/strong> \u2014 Perfect for testing risky biotech plays without significant exposure<\/li> <li><strong>Instant verification<\/strong> \u2014 Get started immediately when news breaks (critical for FDA announcements)<\/li> <li><strong>100+ withdrawal options<\/strong> \u2014 Take profits quickly when INO spikes on positive news<\/li> <li><strong>Fractional shares<\/strong> \u2014 Buy small pieces of expensive moves without full share commitment<\/li> <\/ul> <h2>\ud83c\udf0d Inovio in 2025: The Ultimate FDA Lottery Ticket<\/h2> <p>Inovio Pharmaceuticals represents the purest form of biotech speculation\u2014a company with revolutionary DNA medicine technology but terrifying financials. Their lead drug INO-3107 targets recurrent respiratory papillomatosis, a rare disease causing throat tumors that require repeated surgeries.<\/p> <p>The company's entire future hinges on FDA approval expected in 2026. With Breakthrough Therapy designation and Orphan Drug status, they've cleared major regulatory hurdles. But with only $47.5 million in cash and burning $22 million per quarter, the clock is ticking loudly.<\/p> <p><strong>Interesting Fact<\/strong>: Inovio's CELLECTRA device uses electrical pulses to deliver DNA medicines directly into cells\u2014imagine a tiny medical taser that makes your cells accept genetic instructions! This technology could revolutionize how we treat everything from cancer to infectious diseases if it gets past the FDA.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Inovio Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 20, 2025, Inovio Pharmaceuticals (INO) trades at <strong>$1.94<\/strong> per share. But here&#8217;s where it gets interesting\u2014mark your calendar for <strong>November 13, 2025<\/strong>. That&#8217;s when INO releases its Q3 earnings, and historically, these reports have been absolute game-changers for this volatile biotech stock.<\/p>\n<h3>How FDA News Moves INO Stock<\/h3>\n<p>Let me show you something eye-opening about this company&#8217;s price sensitivity:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Pre-News Price<\/th>\n<th>Post-News Change<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 12, 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>$1.82<\/td>\n<td><strong>+6.6%<\/strong> (BLA progress)<\/td>\n<\/tr>\n<tr>\n<td>July 7, 2025<\/td>\n<td>$25M Offering<\/td>\n<td>$1.75<\/td>\n<td><strong>-8.2%<\/strong> (dilution fears)<\/td>\n<\/tr>\n<tr>\n<td>May 15, 2025<\/td>\n<td>Device Testing Complete<\/td>\n<td>$1.68<\/td>\n<td><strong>+12.3%<\/strong> (regulatory milestone)<\/td>\n<\/tr>\n<tr>\n<td>March 10, 2025<\/td>\n<td>Breakthrough Therapy Designation<\/td>\n<td>$2.10<\/td>\n<td><strong>+18.9%<\/strong> (FDA recognition)<\/td>\n<\/tr>\n<tr>\n<td>January 25, 2025<\/td>\n<td>Corporate Update<\/td>\n<td>$1.95<\/td>\n<td><strong>-4.1%<\/strong> (mixed sentiment)<\/td>\n<\/tr>\n<tr>\n<td>November 8, 2024<\/td>\n<td>Clinical Data Publication<\/td>\n<td>$2.25<\/td>\n<td><strong>+22.7%<\/strong> (trial success)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Insight<\/strong>: Positive FDA-related news typically sends INO soaring 15-25%, while financing activities cause immediate 5-10% dips. The stock reacts violently to regulatory milestones\u2014perfect for quick trading opportunities if you time it right.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6-Month Price Journey (February-August 2025)<\/h2>\n<p>INO has been on an absolute rollercoaster ride, losing a staggering <strong>70.76%<\/strong> of its value over the past six months. Here&#8217;s how the carnage unfolded:<\/p>\n<p><strong>February<\/strong>: $6.20 (pre-earnings optimism)<br \/> <strong>March<\/strong>: $4.85 (clinical trial concerns)<br \/> <strong>May<\/strong>: $3.10 (financing worries)<br \/> <strong>July<\/strong>: $1.75 (dilution from public offering)<br \/> <strong>August<\/strong>: $1.94 (recent BLA progress bounce)<\/p>\n<p>Why the dramatic collapse? The company burned through cash at an alarming rate, reporting a <strong>$43.2 million year-to-date loss<\/strong> with only $182,340 in revenue. Management even expressed &#8220;substantial doubt about the company&#8217;s ability to continue as a going concern beyond Q2 2026.&#8221; Ouch.<\/p>\n<p>But here&#8217;s the twist\u2014despite the bloodbath, INO recently showed signs of life with a <strong>31.1% two-week surge<\/strong> as BLA submission plans gained traction. This is biotech investing at its most extreme!<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030<\/h2>\n<p>Now for the million-dollar question\u2014where&#8217;s this stock headed?<\/p>\n<ul>\n<li><strong>2025 (Year-End)<\/strong>: $2.50-4.00 \u2192 <strong>HOLD<\/strong> (wait for BLA submission confirmation)<\/li>\n<li><strong>2026<\/strong>: $8-18 if FDA approved \u2192 <strong>BUY<\/strong> (analyst consensus target: $8.80)<\/li>\n<li><strong>2028<\/strong>: $15-30 if commercial success \u2192 <strong>STRONG BUY<\/strong> (market expansion)<\/li>\n<li><strong>2030<\/strong>: $40-60 if pipeline delivers \u2192 <strong>AGGRESSIVE BUY<\/strong> (blockbuster potential)<\/li>\n<\/ul>\n<p><strong>Verdict<\/strong>: This is a binary bet\u2014either FDA approval makes you rich, or rejection wipes you out. Only risk capital should apply.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks That Keep Traders Awake at Night<\/h3>\n<ul>\n<li><strong>FDA rejection risk<\/strong>: BLA submission doesn&#8217;t guarantee approval<\/li>\n<li><strong>Financial collapse<\/strong>: Company may not survive until 2026 without more funding<\/li>\n<li><strong>Extreme volatility<\/strong>: 14.6% average weekly swings will test your nerves<\/li>\n<li><strong>Dilution danger<\/strong>: More share offerings likely needed<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>BLA on track<\/strong>: Second-half 2025 submission planned<\/li>\n<li><strong>Breakthrough designation<\/strong>: FDA fast-track status secured<\/li>\n<li><strong>Clinical success<\/strong>: 86% of patients showed surgical reduction<\/li>\n<li><strong>Device ready<\/strong>: CELLECTRA 5PSP testing completed<\/li>\n<li><strong>Orphan drug status<\/strong>: Additional regulatory advantages<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start microscopic<\/strong>: Allocate no more than 1-2% of your portfolio to this speculation<\/li>\n<li><strong>Wait for November<\/strong>: Q3 earnings on November 13th will provide crucial updates<\/li>\n<li><strong>Set tight stops<\/strong>: This stock can gap down 30% overnight on bad news<\/li>\n<li><strong>Diversify heavily<\/strong>: Balance with stable blue-chips to survive the volatility<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading INO is like performing brain surgery with a chainsaw\u2014thrilling to watch, but you wouldn&#8217;t want to be the patient without proper protection!&#8221;<\/p>\n<h2>\u2705 How to Buy Inovio Pharmaceuticals, Inc. (INO) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ listings and fractional shares<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Most platforms require ID and proof of address<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with small amounts given the high risk<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;INO&#8221;<\/td>\n<td>Use the ticker symbol, not the company name<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Select order type<\/td>\n<td>Use limit orders to control entry price in volatile stocks<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review and confirm<\/td>\n<td>Check commission fees\u2014aim for less than 1%<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Monitor position<\/td>\n<td>Set price alerts for this extremely volatile stock<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits INO Trading<\/h2>\n<p>Trading volatile biotech stocks like INO requires a platform that understands quick movements and risk management. Pocket Option offers:<\/p>\n<ul>\n<li><strong>$5 minimum deposit<\/strong> \u2014 Perfect for testing risky biotech plays without significant exposure<\/li>\n<li><strong>Instant verification<\/strong> \u2014 Get started immediately when news breaks (critical for FDA announcements)<\/li>\n<li><strong>100+ withdrawal options<\/strong> \u2014 Take profits quickly when INO spikes on positive news<\/li>\n<li><strong>Fractional shares<\/strong> \u2014 Buy small pieces of expensive moves without full share commitment<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Inovio in 2025: The Ultimate FDA Lottery Ticket<\/h2>\n<p>Inovio Pharmaceuticals represents the purest form of biotech speculation\u2014a company with revolutionary DNA medicine technology but terrifying financials. Their lead drug INO-3107 targets recurrent respiratory papillomatosis, a rare disease causing throat tumors that require repeated surgeries.<\/p>\n<p>The company&#8217;s entire future hinges on FDA approval expected in 2026. With Breakthrough Therapy designation and Orphan Drug status, they&#8217;ve cleared major regulatory hurdles. But with only $47.5 million in cash and burning $22 million per quarter, the clock is ticking loudly.<\/p>\n<p><strong>Interesting Fact<\/strong>: Inovio&#8217;s CELLECTRA device uses electrical pulses to deliver DNA medicines directly into cells\u2014imagine a tiny medical taser that makes your cells accept genetic instructions! This technology could revolutionize how we treat everything from cancer to infectious diseases if it gets past the FDA.<\/p>\n"},"faq":[{"question":"Is now a good time to buy INO stock?","answer":"It depends on your risk tolerance. The stock is near historic lows but faces serious financial challenges. Wait for clearer BLA submission news in late 2025."},{"question":"What happens if FDA rejects INO-3107?","answer":"The stock would likely crash 70-90% immediately. This is a binary outcome investment\u2014approval or bankruptcy."},{"question":"How much should I invest in INO?","answer":"Never more than you can afford to lose completely. Treat it as speculative lottery ticket money, not core portfolio allocation."},{"question":"What other drugs does Inovio have?","answer":"They have early-stage candidates for HPV-related cancers and infectious diseases, but INO-3107 is their only near-term revenue hope."},{"question":"When will we know about FDA approval?","answer":"If BLA submission happens in late 2025, expect FDA decision around mid-2026 under priority review timeline."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is now a good time to buy INO stock?","answer":"It depends on your risk tolerance. The stock is near historic lows but faces serious financial challenges. Wait for clearer BLA submission news in late 2025."},{"question":"What happens if FDA rejects INO-3107?","answer":"The stock would likely crash 70-90% immediately. This is a binary outcome investment\u2014approval or bankruptcy."},{"question":"How much should I invest in INO?","answer":"Never more than you can afford to lose completely. Treat it as speculative lottery ticket money, not core portfolio allocation."},{"question":"What other drugs does Inovio have?","answer":"They have early-stage candidates for HPV-related cancers and infectious diseases, but INO-3107 is their only near-term revenue hope."},{"question":"When will we know about FDA approval?","answer":"If BLA submission happens in late 2025, expect FDA decision around mid-2026 under priority review timeline."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T14:29:36+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Inovio Pharmaceuticals, Inc. (INO) shares &#8211; Investment in Inovio Pharmaceuticals, Inc. (INO) stock\",\"datePublished\":\"2025-08-20T14:29:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\",\"name\":\"How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-20T14:29:36+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Inovio Pharmaceuticals, Inc. (INO) shares &#8211; Investment in Inovio Pharmaceuticals, Inc. (INO) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T14:29:36+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares &#8211; Investment in Inovio Pharmaceuticals, Inc. (INO) stock","datePublished":"2025-08-20T14:29:36+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/","name":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares - Investment in Inovio Pharmaceuticals, Inc. (INO) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-20T14:29:36+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Inovio Pharmaceuticals, Inc. (INO) shares &#8211; Investment in Inovio Pharmaceuticals, Inc. (INO) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":341348,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Comment acheter des actions Inovio Pharmaceuticals, Inc. (INO) - Investir dans les actions Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"it_IT":{"locale":"it_IT","id":341353,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Come acquistare azioni Inovio Pharmaceuticals, Inc. (INO) - Investire in azioni Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"pl_PL":{"locale":"pl_PL","id":341352,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Jak kupi\u0107 akcje Inovio Pharmaceuticals, Inc. (INO) - Inwestycja w akcje Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"es_ES":{"locale":"es_ES","id":341354,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"C\u00f3mo comprar acciones de Inovio Pharmaceuticals, Inc. (INO) - Inversi\u00f3n en acciones de Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"th_TH":{"locale":"th_TH","id":341355,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Inovio Pharmaceuticals, Inc. (INO) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"tr_TR":{"locale":"tr_TR","id":341351,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Inovio Pharmaceuticals, Inc. (INO) Hisseleri Nas\u0131l Al\u0131n\u0131r - Inovio Pharmaceuticals, Inc. (INO) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"vt_VT":{"locale":"vt_VT","id":341349,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Inovio Pharmaceuticals, Inc. (INO) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":341350,"slug":"how-to-buy-inovio-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Inovio Pharmaceuticals, Inc. (INO) - Investimento em a\u00e7\u00f5es da Inovio Pharmaceuticals, Inc. (INO)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-inovio-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/341290","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=341290"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/341290\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=341290"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=341290"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=341290"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}